Evaluation of PBRM1, PD-L1, CD31 and CD4/CD8 ratio as predictive biomarkers of response to VEGFR-TKI-based therapy in metastatic renal cell carcinoma (mRCC) patients with IMDC intermediate prognosis: Results from the APAChE-I study

Autor:	C. Ciccarese, S. Buti, M. Roberto, F. Calabrò, C. Masini, F. Massari, M. Cannella, G. Mazzaschi, S. Astore, S. Di Girolamo, M. Panebianco, V. Mollica, A. Granitto, V. Fiorentino, F. Pierconti, M. Martini, C. Porta, G. Tortora, R. Iacovelli
Rok vydání:	2023
Předmět:	Urology
Zdroj:	European Urology. 83:S1490-S1491
ISSN:	0302-2838
DOI:	10.1016/s0302-2838(23)01073-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3c5df858f12a8289134028b699e553df https://doi.org/10.1016/s0302-2838(23)01073-4 Zobrazit plný text záznamu Full Text from ScienceDirect